Page last updated: 2024-09-04

glucagon and sybr green i

glucagon has been researched along with sybr green i in 1 studies

Compound Research Comparison

Studies
(glucagon)
Trials
(glucagon)
Recent Studies (post-2010)
(glucagon)
Studies
(sybr green i)
Trials
(sybr green i)
Recent Studies (post-2010) (sybr green i)
26,0391,4983,0541,1121516

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benjes, C; Crowley, A; Gittes, G; Hembree, M; McFall, C; Mehta, S; Prasadan, K; Preuett, B; Sharp, S; Tei, E; Tulachan, S; Yew, KH1

Other Studies

1 other study(ies) available for glucagon and sybr green i

ArticleYear
Cross-talk between bone morphogenetic protein and transforming growth factor-beta signaling is essential for exendin-4-induced insulin-positive differentiation of AR42J cells.
    The Journal of biological chemistry, 2005, Sep-16, Volume: 280, Issue:37

    Topics: Animals; Benzothiazoles; Blotting, Western; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cell Differentiation; Diamines; DNA Primers; DNA-Binding Proteins; Dose-Response Relationship, Drug; Exenatide; Glucagon; Glucagon-Like Peptide 1; Insulin; Islets of Langerhans; Ligands; Organic Chemicals; Peptide Fragments; Peptides; Phosphoproteins; Polymerase Chain Reaction; Protein Binding; Protein Isoforms; Protein Precursors; Quinolines; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Smad Proteins; Smad1 Protein; Smad5 Protein; Smad8 Protein; Trans-Activators; Transforming Growth Factor beta; Venoms

2005